Filip Farnebo

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Forskningsbeskrivning

Forskargruppsledare för gruppen Rekonstruktiv plastikkirurgi [1]
[1] http://ki.se/mmk/rekonstruktiv-plastikkirurgi-0

Artiklar

Article: JACC: BASIC TO TRANSLATIONAL SCIENCE. 2022;7(3):193-204
Erythrocytes Induce Vascular Dysfunction in COVID-19
Mahdi A; Collado A; Tengbom J; Jiao T; Wodaje T; Johansson N; Farnebo F; Farnert A; Yang J; Lundberg JO; Zhou Z; Pernow J
Article: PLASTIC AND RECONSTRUCTIVE SURGERY - GLOBAL OPEN. 2021;9(7):e3628
Improved Surgical Outcome with Double Incision and Free Nipple Graft in Gender Confirmation Mastectomy
Kamali A; Sigurjonsson H; Gran I; Farnebo F; Conneryd Lundgren K; Granath F; Sommar P
Article: JOURNAL OF CRANIOFACIAL SURGERY. 2019;30(5):1383-1386
Management of the Midface in the Transgender Patient
Natghian H; Farnebo F; Lundgren KC
Article: JOURNAL OF CRANIOFACIAL SURGERY. 2017;28(2):391-393
Lower Eyelid Complications in Facial Fracture Surgery
Neovius E; Clarliden S; Farnebo F; Lundgren TK
Article: JOURNAL OF SEXUAL MEDICINE. 2017;14(2):269-273
Long-Term Sensitivity and Patient-Reported Functionality of the Neoclitoris After Gender Reassignment Surgery
Sigurjonsson H; Mollermark C; Rinder J; Farnebo F; Lundgren TK
Article: EUROPEAN JOURNAL OF PLASTIC SURGERY. 2017;40(3):223-226
Quality of life improves early after gender reassignment surgery in transgender women.
Lindqvist EK; Sigurjonsson H; Möllermark C; Rinder J; Farnebo F; Lundgren TK
Article: PLASTIC AND RECONSTRUCTIVE SURGERY, GLOBAL OPEN. 2017;5(1):e1210
Midface Osteotomies for Feminization of the Facial Skeleton.
Lundgren TK; Farnebo F
Article: JOURNAL OF PLASTIC, RECONSTRUCTIVE AND AESTHETIC SURGERY. 2017;70(1):120-126
Long-term sensory disturbances after orbitozygomatic fractures
Neovius E; Fransson M; Persson C; Clarliden S; Farnebo F; Lundgren TK
Article: PLASTIC AND RECONSTRUCTIVE SURGERY, GLOBAL OPEN. 2016;4(6):e767
Solely Penile Skin for Neovaginal Construction in Sex Reassignment Surgery.
Sigurjonsson H; Rinder J; Lindqvist EK; Farnebo F; Lundgren TK
Article: JOURNAL OF PLASTIC, RECONSTRUCTIVE AND AESTHETIC SURGERY. 2015;68(2):219-225
Persistent diplopia after fractures involving the orbit related to nerve injury
Neovius E; Fransson M; Matthis SP; Persson C; Ostlund S; Farnebo F; Lundgren TK
Article: STEM CELLS AND DEVELOPMENT. 2013;22(9):1360-1369
Hypoxia-Induced Arterial Differentiation Requires Adrenomedullin and Notch Signaling
Lanner F; Lee KL; Ortega GC; Sohl M; Li X; Jin S; Hansson EM; Claesson-Welsh L; Poellinger L; Lendahl U; Farnebo F
Article: APMIS. 2012;120(10):786-793
Protective immunization against Staphylococcus aureus infection in a novel experimental wound model in mice
Schennings T; Farnebo F; Szekely L; Flock J-I
Article: JOURNAL OF PLASTIC, RECONSTRUCTIVE AND AESTHETIC SURGERY. 2010;63(11):1910-1916
Endothelial activation with prothrombotic response in irradiated microvascular recipient veins
Halle M; Ekstrom M; Farnebo F; Tornvall P
Article: JOURNAL OF CELL SCIENCE. 2010;123(17):2931-2942
Control of Notch-ligand endocytosis by ligand-receptor interaction
Hansson EM; Lanner F; Das D; Mutvei A; Marklund U; Ericson J; Farnebo F; Stumm G; Stenmark H; Andersson ER; Lendahl U
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2010;55(12):1227-1236
Sustained Inflammation Due to Nuclear Factor-Kappa B Activation in Irradiated Human Arteries
Halle M; Gabrielsen A; Paulsson-Berne G; Gahm C; Agardh HE; Farnebo F; Tornvall P
Article: STEM CELLS. 2010;28(2):191-200
Heparan Sulfation-Dependent Fibroblast Growth Factor Signaling Maintains Embryonic Stem Cells Primed for Differentiation in a Heterogeneous State
Lanner F; Lee KL; Sohl M; Holmborn K; Yang H; Wilbertz J; Poellinger L; Rossant J; Farnebo F
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2010;391(1):24-27
Sp1 mediate hypoxia induced ephrinB2 expression via a hypoxia-inducible factor independent mechanism
Sohl M; Lanner F; Farnebo F
Article: GENE. 2009;437(1-2):54-59
Characterization of the murine Ephrin-B2 promoter
Sohl M; Lanner F; Farnebo F
Article: CARDIOVASCULAR RESEARCH (CVR). 2009;82(1):107-114
Cardioprotection by hypoxia-inducible factor 1 alpha transfection in skeletal muscle is dependent on haem oxygenase activity in mice
Czibik G; Sagave J; Martinov V; Ishaq B; Sohl M; Sefland I; Carlsen H; Farnebo F; Blomhoff R; Valen G
Article: INTERNATIONAL JOURNAL OF CANCER. 2008;123(2):389-394
Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma
Geli J; Kogner P; Lanner F; Natalishvili N; Juhlin C; Kiss N; Clark GJ; Ekstrom TJ; Farnebo F; Larsson C
Article: CLINICAL INFECTIOUS DISEASES. 2008;47(2):e11-e16
Late-onset posttraumatic skin and soft-tissue infections caused by rapid-growing mycobacteria in tsunami survivors
Appelgren P; Farnebo F; Dotevall L; Studahl M; Jonsson B; Petrini B
Article: CIRCULATION RESEARCH. 2008;102(12):1483-1491
Notch signaling regulates platelet-derived growth factor receptor-β expression in vascular smooth muscle cells
Jin S; Hansson EM; Tikka S; Lanner F; Sahlgren C; Farnebo F; Baumann M; Kalimo H; Lendahl U
Article: STEM CELLS. 2007;25(12):2987-2995
Lentiviral rescue of vascular endothelial growth factor receptor-2 expression in Flk1-/- embryonic stem cells shows early priming of endothelial precursors
Li X; Edholm D; Lanner F; Breier G; Farnebo F; Dimberg A; Claesson-Welsh L
Article: ENDOCRINE-RELATED CANCER. 2007;14(1):125-134
The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma
Geli J; Kiss N; Lanner F; Foukakis T; Natalishvili N; Larsson O; Kogner P; Hoog A; Clark GJ; Ekstrom TJ; Backdahl M; Farnebo F; Larsson C
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2007;27(3):487-493
Functional arterial and venous fate is determined by graded VEGF signaling and notch status during embryonic stem cell differentiation
Lanner F; Sohl M; Farnebo F
Article: EXPERIMENTAL CELL RESEARCH. 2007;313(2):284-291
Consequences of Shb and c-Abl interactions for cell death in response to various stress stimuli
Hagerkvist R; Mokhtari D; Lindholm C; Farnebo F; Mostoslavsky G; Mulligan RC; Welsh N; Welsh M
Article: MEDICAL MYCOLOGY. 2006;44(2):189-192
Concomitant late soft tissue infections by Cladophialophora bantiana and Mycobacterium abscessus following tsunami injuries
Petrini B; Farnebo F; Hedblad MA; Appelgren P
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2004;101(32):11658-11663
Dose-dependent response of FGF-2 for lymphangiogenesis.
Chang LK; Garcia-Cardeña G; Farnebo F; Fannon M; Chen EJ; Butterfield C; Moses MA; Mulligan RC; Folkman J; Kaipainen A
Article: CANCER BIOLOGY & THERAPY. 2002;1(5):548-553
Gene therapy of prostate cancer with the soluble vascular endothelial growth factor receptor Flk1.
Becker CM; Farnebo FA; Iordanescu I; Behonick DJ; Shih M-C; Dunning P; Christofferson R; Mulligan RC; Taylor GA; Kuo CJ; Zetter BR
Article: CLINICAL ENDOCRINOLOGY. 2002;56(2):261-269
Genetic and clinical characterization of sporadic cystic parathyroid tumours.
Villablanca A; Farnebo F; Teh BT; Farnebo L-O; Höög A; Larsson C
Article: CLINICAL ENDOCRINOLOGY. 2002;56(2):259-267
Genetic and clinical characterization of sporadic cystic parathyroid tumours
Villablanca A; Farnebo F; Teh BT; Farnebo LO; Höög A; Larsson C
Article: KIDNEY INTERNATIONAL. 2001;60(5):1666-1675
Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism
Välimäki S; Farnebo F; Forsberg L; Larsson C; Farnebo LO
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY (EJE). 2001;145(4):415-420
Homozygous inactivation of the MEN1 gene as a specific somatic event in a case of secondary hyperparathyroidism
Forsberg L; Villablanca A; Välimäki S; Farnebo F; Farnebo LO; Lagercrantz S; Larsson C
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2001;66(5):297-304
Identification of numerical and structural chromosome aberrations in 15 high hyperdiploid childhood acute lymphoblastic leukemias using spectral karyotyping
Nordgren A; Farnebo F; Johansson B; Holmgren G; Forestier E; Larsson C; Söderhäll S; Nordenskjöld M; Blennow E
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2001;98(8):4605-4610
Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer.
Kuo CJ; Farnebo F; Yu EY; Christofferson R; Swearingen RA; Carter R; von Recum HA; Yuan J; Kamihara J; Flynn E; D'Amato R; Folkman J; Mulligan RC
Article: CANCER GENETICS. 2001;126(1):1-7
Aberrations of chromosome 8 in 16 breast cancer cell lines by comparative genomic hybridization, fluorescence in situ hybridization, and spectral karyotyping
Rummukainen J; Kytölä S; Karhu R; Farnebo F; Larsson C; Isola JJ
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2000;6(4):469-474
Expression analysis of RET and the GDNF/GFRa-1 and NTN/GFRa-2 ligand complexes in pheochromocytomas and paragangliomas
Edström E; Frisk T; Farnebo F; Höög A; Bäckdahl M; Larsson C
Article: AMERICAN JOURNAL OF PATHOLOGY. 2000;157(2):579-586
Patterns of chromosomal imbalances in parathyroid carcinomas
Kytölä S; Farnebo F; Obara T; Isola J; Grimelius L; Farnebo LO; Sandelin K; Larsson C
Article: CLINICAL ENDOCRINOLOGY. 2000;53(1):85-92
Loss of heterozygosity in sporadic parathyroid tumours:: involvement of chromosome 1 and the MEN1 gene locus in 11q13.
Dwight T; Twigg S; Delbridge L; Wong FK; Farnebo F; Richardson AL; Nelson A; Zedenius J; Philips J; Larsson C; Teh BT; Robinson B
Article: GENES CHROMOSOMES AND CANCER. 2000;28(3):308-317
Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping
Kytölä S; Rummukainen J; Nordgren A; Karhu R; Farnebo F; Isola J; Larsson C
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY (EJE). 2000;142(6):643-649
Expression of RET and its ligand complexes, GDNF/GFRalpha-1 and NTN/GFRalpha-2, in medullary thyroid carcinomas
Frisk T; Farnebo F; Zedenius J; Grimelius L; Höög A; Wallin G; Larsson C
Article: HEMATOLOGY JOURNAL. 2000;1(2):95-101
Detailed characterization of a complex karyotype in a patient with primary plasma cell leukaemia using multicolour spectral karyotyping and micro-FISH.
Nordgren A; Farnebo F; Björkholm M; Sahlén S; Porwit-MacDonald A; Osby E; Kytölä S; Larsson C; Nordenskjöld M; Blennow E
Article: MAMMALIAN GENOME. 2000;11(1):78-80
Molecular characterization of human and murine C11orf5, a new member of the FAUNA gene cluster
Lemmens IH; Farnebo F; Piehl F; Merregaert J; Van de Ven WJM; Larsson C; Kas K
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 1999;84(10):3775-3780
Alternative genetic pathways in parathyroid tumorigenesis
Farnebo F; Kytölä S; Teh BT; Dwight T; Wong FK; Höög A; Elvius M; Wassif WS; Thompson NW; Farnebo LO; Sandelin K; Larsson C
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1999;257(3):891-894
Restricted expression pattern of vegf-d in the adult and fetal mouse:: High expression in the embryonic lung
Farnebo F; Piehl F; Lagercrantz J
Article: CLINICAL ENDOCRINOLOGY. 1999;50(2):191-196
Genetic studies of a family with hereditary hyperparathyroidism jaw tumour syndrome
Wassif WS; Farnebo F; Teh BT; Moniz CF; Li FY; Harrison JD; Peters TJ; Larsson C; Harris P
Article: WORLD JOURNAL OF SURGERY. 1999;23(1):68-74
Evaluation of retinoblastoma and Ki-67 immunostaining as diagnostic markers of benign and malignant parathyroid disease
Farnebo F; Auer G; Farnebo LO; Teh BT; Twigg S; Aspenblad U; Thompson NW; Grimelius L; Larsson C; Sandelin K
Article: CYTOGENETIC AND GENOME RESEARCH. 1999;87(3-4):225-232
Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping
Pan Y; Kytölä S; Farnebo F; Wang N; Lui WO; Nupponen N; Isola J; Visakorpi T; Bergerheim USR; Larsson C
Article: ONCOGENE. 1998;17(19):2485-2493
Characterization of the mouse Men1 gene and its expression during development
Stewart C; Parente F; Piehl F; Farnebo F; Quincey D; Silins G; Bergman L; Carle GF; Lemmens I; Grimmond S; Xian CZ; Khodei S; Teh BT; Lagercrantz J; Siggers P; Calender A; Van de Vem V; Kas K; Weber G; Hayward N; Gaudray P; Larsson C
Article: MAMMALIAN GENOME. 1998;9(8):660-665
Expression and chromosomal localization of the Requiem gene
Gabig TG; Crean CD; Klenk A; Long HY; Copeland NG; Gilbert DJ; Jenkins NA; Quincey D; Parente F; Lespinasse F; Carle GF; Gaudray P; Zhang CX; Calender A; Hoeppener J; Kas K; Thakker RV; Farnebo F; Teh BT; Larsson C; Piehl F; Lagercrantz J; Khodaei S; Carson E; Weber G
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 1998;83(8):2627-2630
Alterations of the MEN1 gene in sporadic parathyroid tumors
Farnebo F; Teh BT; Kytölä S; Svensson A; Phelan C; Sandelin K; Thompson NW; Höög A; Weber G; Farnebo LO; Larsson C
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 1998;83(8):2621-2626
Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism
Teh BT; Kytölä S; Farnebo F; Bergman L; Wong FK; Weber G; Hayward N; Larsson C; Skogseid B; Beckers A; Phelan C; Edwards M; Epstein M; Alford F; Hurley D; Grimmond S; Silins G; Walters M; Stewart C; Cardinal J; Khodaei S; Parente F; Tranebjaerg L; Jorde R; Menon J; Khir A; Tan TT; Chan SP; Zaini A; Khalid BAK; Sandelin K; Thompson N; Brandi ML; Warth M; Stock J; Leisti J; Cameron D; Shepherd JJ; Öberg K; Nordenskjöld M; Salmela P
Article: ANNALS OF SURGERY. 1998;228(1):99-105
Thymic carcinoids in multiple endocrine neoplasia type 1
Teh BT; Zedenius J; Kytölä S; Skogseid B; Trotter J; Choplin H; Twigg S; Farnebo F; Giraud S; Cameron D; Robinson B; Calender A; Larsson C; Salmela P
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1998;247(2):357-360
Expression of the BCL6 gene in the pre- and postnatal mouse
Bajalica-Lagercrantz S; Piehl F; Farnebo F; Larsson C; Lagercrantz J
Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 1998;1398(2):157-163
A comparative study of the expression patterns for vegf, vegf-b/vrf and vegf-c in the developing and adult mouse
Lagercrantz J; Farnebo F; Larsson C; Tvrdik T; Weber G; Piehl F
Article: GENOMICS. 1998;50(2):251-259
A putative human zinc-finger gene (ZFPL1) on 11q13, highly conserved in the mouse and expressed in exocrine pancreas -: The European Consortium on MEN 1
Höppener JWM; De Wit MJ; Simarro-Doorten AY; Roijers JFM; van Herrewaarden HMC; Lips CJM; Parente F; Quincey D; Gaudray P; Khodaei S; Weber G; Teh B; Farnebo F; Larsson C; Zhang CX; Calender A; Pannett AAJ; Forbes SA; Bassett JHT; Thakker RV; Lemmens I; Van de Ven WJM; Kas K
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 1998;83(6):2114-2120
Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families
Teh BT; Farnebo F; Twigg S; Höög A; Kytölä S; Korpi-Hyövälti E; Wong FK; Nordenström J; Grimelius L; Sandelin K; Robinson B; Farnebo LO; Larsson C
Article: MAMMALIAN GENOME. 1998;9(4):310-311
Mapping of the human Ca²⁺ channel β₄ subunit to 2q22-23 and its expression in developing mouse
Betz R; Leibiger B; Farnebo F; Lagercrantz S; Piehl F; Leibiger I; Larsson C
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 1997;82(10):3481-3486
Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism
Farnebo F; Enberg U; Grimelius L; Backdahl M; Schalling M; Larsson C; Farnebo LO
Article: GENOMICS. 1997;44(1):94-100
Construction of a 1.2-Mb sequence-ready contig of chromosome 11q13 encompassing the multiple endocrine neoplasia type 1 (MEN1) gene - The European consortium on type 1 (MEN1) gene
Lemmens I; Merregaert J; VandeVen WJM; Kas K; Zhang CX; Giraud S; Wautot V; Buisson N; DeWitte K; Salandre J; Lenoir G; Calender A; Parente F; Quincey D; Courseaux A; Carle GF; Gaudray P; DeWit MJ; Lips CJM; Hoppener JWM; Khodaei S; Grant AL; Weber G; Kytola S; Teh BT; Farnebo F; Grimmond S; Phelan C; Larsson C; Forbes SA; Bassett JHD; Pannett AAJ; Thakker RV
Article: HUMAN MOLECULAR GENETICS. 1997;6(7):1177-1183
Identification of the multiple endocrine neoplasia type 1 (MEN1) gene
Lemmens I; VandeVen WJM; Kas K; Zhang CX; Giraud S; Wautot V; Buisson N; DeWitte K; Salandre J; Lenoir G; Pugeat M; Calender A; Parente F; Quincey D; Gaudray P; DeWit MJ; Lips CJM; Hoppener JWM; Khodaei S; Grant AL; Weber G; Kytola S; Teh BT; Farnebo F; Phelan C; Hayward N; Larsson C; Pannett AAJ; Forbes SA; Bassett JHD; Thakker RV
Article: BRITISH JOURNAL OF SURGERY. 1997;163(5):331-337
Allelic loss on chromosome 11 is uncommon in parathyroid glands of patients with hypercalcaemic secondary hyperparathyroidism
Farnebo F; Farnebo LO; Nordenstrom J; Larsson C
Article: HUMAN GENETICS. 1997;99(3):342-349
Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism
Farnebo F; Teh BT; Dotzenrath C; Wassif WS; Svensson A; White I; Betz R; Goretzki P; Sandelin K; Farnebo LO; Larsson C
Article: CLINICAL GENETICS. 1997;51(1):52-55
Oculopharyngeal muscular dystrophy (OPMD) - Report and genetic studies of an Australian kindred
Teh BT; Sullivan AA; Farnebo F; Zander C; Li FY; Strachan N; Schalling M; Larsson C; Sandstrom P
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 1996;81(12):4204-4211
Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: Linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas
Teh BT; Farnebo F; Kristoffersson U; Sundelin B; Cardinal J; Axelson R; Yap A; Epstein M; Heath H; Cameron D; Larsson C
Article: GENOMICS. 1996;37(3):354-365
Definition of the minimal MEN1 candidate area based on a 5-Mb integrated map of proximal 11q13. The European Consortium on Men1, (GENEM 1; Groupe d'Etude des Néoplasies Endocriniennes Multiples de type 1).
Courseaux A; Grosgeorge J; Gaudray P; Pannett AA; Forbes SA; Williamson C; Bassett D; Thakker RV; Teh BT; Farnebo F; Shepherd J; Skogseid B; Larsson C; Giraud S; Zhang CX; Salandre J; Calender A
Article: GENOMICS. 1996;37(3):345-353
Definition of the minimal MEN1 candidate area based on a 5-Mb integrated map of proximal 11q13 - The European consortium on MEN1
Courseaux A; Grosgeorge J; Gaudray P; Pannett AAJ; Forbes SA; Williamson C; Bassett D; Thakker RV; Teh BT; Farnebo F; Shepherd J; Skogseid B; Larsson C; Giraud S; Zhang CX; Salandre J; Calender A
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM (JCEM). 1996;81(9):3194-3196
Allelic loss of the retinoblastoma tumor suppressor gene: A marker for aggressive parathyroid tumors?
Dotzenrath C; Teh BT; Farnebo F; Cupisti K; Svensson A; Toell A; Goretzki P; Larsson C
Article: JOURNAL OF INTERNAL MEDICINE. 1995;238(3):239-244
MOLECULAR TOOLS FOR PRESYMPTOMATIC TESTING IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-1
LARSSON C; CALENDER A; GRIMMOND S; GIRAUD S; HAYWARD NK; TEH B; FARNEBO F
Visa fler

Alla övriga publikationer

Letter: ARCHIVES OF SEXUAL BEHAVIOR. 2017;46(6):1573-1576
Craniofacial Reconstructive Surgery Improves Appearance Congruence in Male-to-Female Transsexual Patients
Isung J; Mollermark C; Farnebo F; Lundgren K
Corrigendum: ARCHIVES OF SEXUAL BEHAVIOR. 2016;45(8):1881
Moving Transgender Care Forward within Public Health Organizations: Inclusion of Facial Feminizing Surgery in the Swedish National Treatment Recommendations (vol 45, pg 1879, 2016)
Lundgren TK; Isung J; Rinder J; Dhejne C; Arver S; Holm L-E; Farnebo F
Letter: ARCHIVES OF SEXUAL BEHAVIOR. 2016;45(8):1879-1880
Moving Transgender Care Forward within Public Health Organizations: Inclusion of Facial Feminizing Surgery in the Swedish National Treatment Recommendations
Lundgren TK; Isung J; Rinder J; Dhejne C; Arver S; Holm L-E; Farnebo F
Letter: PLASTIC AND RECONSTRUCTIVE SURGERY. 2012;129(3):549e-550e
Does Previous Head and Neck Irradiation Increase Vascular Complications in Free Autologous Reconstruction?
Halle M; Farnebo F
Published conference paper: JOURNAL OF PLASTIC, RECONSTRUCTIVE AND AESTHETIC SURGERY. 2009;62(7):889-895
Timing of radiotherapy in head and neck free flap reconstruction - a study of postoperative complications
Halle M; Bodin I; Tornvall P; Wickman M; Farnebo F; Arnander C
Letter: LAKARTIDNINGEN. 2005;102(14):1079
[Late skin infections following tsunami injuries].
Petrini B; Farnebo F; Appelgren P
Published conference paper: SURGERY. 2002;132(5):857-865
Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice.
Tseng JF; Farnebo FA; Kisker O; Becker CM; Kuo CJ; Folkman J; Mulligan RC
Published conference paper: SURGERY. 1999;126(6):1183-1187
Expression of matrix metalloproteinase gelatinase A messenger ribonucleic acid in parathyroid carcinomas
Farnebo F; Svensson A; Thompson NW; Bäckdahl M; Grimelius L; Larsson C; Farnebo LO; Sandelin K
Meeting abstract: PEDIATRIC RESEARCH. 1999;45(4):144A
Characterization of chromosomal changes in 17 children with acute lymphoblastic leukemia and hyperdiploidy using spectral karyotyping (SKY)
Blennow E; Nordgren A; Farnebo F; Soderhall S; Nordenskjold M
Published conference paper: SURGERY. 1998;124(6):1094-1098
Decreased expression of calcium-sensing receptor messenger ribonucleic acids in parathyroid adenomas
Farnebo F; Höög A; Sandelin K; Larsson C; Farnebo LO
Letter: AMERICAN JOURNAL OF HUMAN GENETICS. 1998;63(5):1544-1549
A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors
Teh BT; Esapa CT; Houlston R; Grandell U; Farnebo F; Nordenskjöld M; Pearce CJ; Carmichael D; Larsson C; Harris PE
Thesis / dissertation: 1998
Molecular mechanisms of tumor development in hyperparathyroidism
Farnebo, Filip
Published conference paper: JOURNAL OF INTERNAL MEDICINE. 1998;243(6):441-446
The search for the MEN1 gene
Lemmes I; Van de Ven WJM; Kas K; Zhang CX; Giraud S; Wautot V; Buisson N; Pugeat M; Peix JL; Caldener A; Parente F; Quincey D; Courseaux A; Carle GF; Gaudray P; De Wit MJ; Lips CJM; Höppener JWM; Khodaei S; Grant AL; Weber G; Teh BT; Farnebo F; Kytölä S; Grimmond S; Phelan C; Larsson C; Bassett JHD; Forbes DA; Pannett AAJ; Thakker RV
Editorial comment: SURGERY. 1998;124(6):1098-1099
Decreased expression of calcium-sensing receptor messenger ribonucleic acids in parathyroid adenomas - Discussion
McHenry CR; Farnebo F; Marx S; Akerstrom G; Mitchell BK
Published conference paper: HORMONE RESEARCH IN PAEDIATRICS. 1997;47(4-6):179-184
Multiple endocrine neoplasia type 1 and the search for the genetic trigger
Farnebo F; Jarhult J; Farnebo LO; Nilsson O; Teh BT; Lagercrantz J; Weber G; Sandelin K; Larsson C
Published conference paper: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY AND DIABETES. 1996;104:105-107
Molecular genetics of primary and secondary hyperparathyroidism
Dotzenrath C; Goretzki PE; Farnebo F; Teh BT; Weber G; Roher HD; Larsson C

Anställningar

Anknuten till Forskning, Molekylär medicin och kirurgi, Karolinska Institutet, 2023-2026

Examina och utbildning

Docent, plastikkirurgi, Karolinska institutet, 2004
Läkarexamen, Karolinska Institutet, 2001
MEDICINE DOKTORSEXAMEN, Institutionen för molekylär medicin och kirurgi, Karolinska Institutet, 1998

Forskningsbeskrivning

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI